Valneva shares jump after saying vaccine candidate outperformed AstraZeneca's
Valneva VLA, +32.50% shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's AZN, -0.
61% in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Prof Sarah Gilbert, Covid vaccine creator: Now let’s take on 12 more diseasesProf Dame Sarah Gilbert says medical science has transformed ambitions for new vaccines.
Baca lebih lajut »
Navy SEALs seeking religious exemptions to vaccine mandate facing intimidation and harassment, sources sayEXCLUSIVE: A growing number of U.S. Navy SEALs who are seeking a religious exemption to the Defense Department's COVID-19 vaccine mandate are being threatened and, in some cases, harassed into submission, Fox News has learned.
Baca lebih lajut »
CDC: It’s Safe to Get COVID, Flu Vaccines at Same TimeThe CDC’s Advisory Committee on Immunization Practices offered several updated recommendations regarding seasonal flu vaccines, most notably the safety of coadministration of COVID-19 and influenza vaccines.
Baca lebih lajut »
In New Hampshire, vaccine fights and misinformation roil GOPRepublicans in New Hampshire are struggling to contain a party wing that's promoting conspiracy views about the COVID-19 vaccine and pushing back against federal vaccine mandates.
Baca lebih lajut »
Adele Considered Three 'Very Different' Options Before Releasing 'Easy on Me' as New SingleAdele picked 'Easy on Me' as the first single from her upcoming album, '30,' but says she could have gone in a very different direction.
Baca lebih lajut »
Fauci: J&J vaccine 'should have been a two-dose vaccine'Fauci said FDA panel's recommendation shows J&J vaccine 'should have been a two-dose vaccine to begin with'
Baca lebih lajut »